Annual ROE
-55.85%
-20.02%-55.87%
September 30, 2024
Summary
- As of February 27, 2025, CTXR annual return on equity is -55.85%, with the most recent change of -20.02% (-55.87%) on September 30, 2024.
- During the last 3 years, CTXR annual ROE has fallen by -38.41% (-220.24%).
- CTXR annual ROE is now -112.22% below its all-time high of 456.91%, reached on September 30, 2015.
Performance
CTXR ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-52.81%
-3.87%-7.91%
December 31, 2024
Summary
- As of February 27, 2025, CTXR quarterly return on equity is -52.81%, with the most recent change of -3.87% (-7.91%) on December 31, 2024.
- Over the past year, CTXR quarterly ROE has dropped by -7.84% (-17.43%).
- CTXR quarterly ROE is now -101.69% below its all-time high of 3131.79%, reached on June 30, 2014.
Performance
CTXR Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
CTXR ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -55.9% | -17.4% |
| 3 y3 years | -220.2% | -17.4% |
| 5 y5 years | +2.5% | -17.4% |
CTXR ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -220.2% | at low | -183.3% | at low |
| 5 y | 5-year | -220.2% | +2.5% | -183.3% | +32.0% |
| alltime | all time | -112.2% | +2.5% | -101.7% | +41.2% |
Citius Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | - | -52.81%(+7.9%) |
| Sep 2024 | -55.85%(+55.9%) | -48.94%(+8.8%) |
| Jun 2024 | - | -44.97%(+9.5%) |
| Mar 2024 | - | -41.06%(-2.0%) |
| Dec 2023 | - | -41.90%(+22.4%) |
| Sep 2023 | -35.83%(+9.5%) | -34.24%(+9.7%) |
| Jun 2023 | - | -31.20%(+1.8%) |
| Mar 2023 | - | -30.65%(+17.8%) |
| Dec 2022 | - | -26.02%(-12.2%) |
| Sep 2022 | - | -29.63%(+17.0%) |
| Sep 2022 | -32.72%(+87.6%) | - |
| Jun 2022 | - | -25.33%(+17.2%) |
| Mar 2022 | - | -21.61%(+15.9%) |
| Dec 2021 | - | -18.64%(-15.3%) |
| Sep 2021 | -17.44%(-66.5%) | -22.00%(-20.6%) |
| Jun 2021 | - | -27.71%(-30.0%) |
| Mar 2021 | - | -39.61%(-49.0%) |
| Dec 2020 | - | -77.68%(+16.5%) |
| Sep 2020 | -52.12%(-9.1%) | -66.70%(-3.6%) |
| Jun 2020 | - | -69.20%(-5.8%) |
| Mar 2020 | - | -73.47%(+3.2%) |
| Dec 2019 | - | -71.22%(+7.2%) |
| Sep 2019 | -57.31%(+27.4%) | -66.42%(+6.2%) |
| Jun 2019 | - | -62.52%(+19.4%) |
| Mar 2019 | - | -52.35%(-3.4%) |
| Dec 2018 | - | -54.19%(+6.8%) |
| Sep 2018 | -44.99% | -50.73%(-7.4%) |
| Jun 2018 | - | -54.80%(-13.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | -63.37%(+1.5%) |
| Dec 2017 | - | -62.44%(-5.8%) |
| Sep 2017 | -47.32%(-4.4%) | -66.26%(-4.1%) |
| Jun 2017 | - | -69.07%(-0.5%) |
| Mar 2017 | - | -69.44%(+32.3%) |
| Dec 2016 | - | -52.48%(-15.0%) |
| Sep 2016 | -49.48%(-110.8%) | -61.72%(-15.2%) |
| Jun 2016 | - | -72.76%(-19.0%) |
| Mar 2016 | - | -89.86%(-129.4%) |
| Dec 2015 | - | 305.22%(-6.5%) |
| Sep 2015 | 456.91%(+113.9%) | 326.36%(+49.9%) |
| Jun 2015 | - | 217.69%(+13.7%) |
| Mar 2015 | - | 191.49%(-18.2%) |
| Dec 2014 | - | 234.02%(-27.9%) |
| Sep 2014 | - | 324.37%(-89.6%) |
| Jun 2014 | - | 3131.79%(+41.8%) |
| Mar 2014 | - | 2208.74%(+45.9%) |
| Dec 2013 | - | 1513.88%(+2093.4%) |
| Sep 2013 | 213.61%(+344.7%) | 69.02%(+71.4%) |
| Jun 2013 | - | 40.28%(-19.1%) |
| Mar 2013 | - | 49.82%(+0.1%) |
| Dec 2012 | - | 49.76%(-17.3%) |
| Sep 2012 | 48.03%(-56.5%) | 60.15%(-3.7%) |
| Jun 2012 | - | 62.43%(-17.7%) |
| Mar 2012 | - | 75.88%(-9.8%) |
| Dec 2011 | - | 84.15%(-28.4%) |
| Sep 2011 | 110.50% | 117.59%(+5.1%) |
| Jun 2011 | - | 111.85% |
FAQ
- What is Citius Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Citius Pharmaceuticals?
- What is Citius Pharmaceuticals annual ROE year-on-year change?
- What is Citius Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Citius Pharmaceuticals?
- What is Citius Pharmaceuticals quarterly ROE year-on-year change?
What is Citius Pharmaceuticals annual return on equity?
The current annual ROE of CTXR is -55.85%
What is the all time high annual ROE for Citius Pharmaceuticals?
Citius Pharmaceuticals all-time high annual return on equity is 456.91%
What is Citius Pharmaceuticals annual ROE year-on-year change?
Over the past year, CTXR annual return on equity has changed by -20.02% (-55.87%)
What is Citius Pharmaceuticals quarterly return on equity?
The current quarterly ROE of CTXR is -52.81%
What is the all time high quarterly ROE for Citius Pharmaceuticals?
Citius Pharmaceuticals all-time high quarterly return on equity is 3131.79%
What is Citius Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, CTXR quarterly return on equity has changed by -7.84% (-17.43%)